Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies. - Wikidata - thesis-toulmin - TriplyDB

Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.

Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.

http://www.wikidata.org/entity/Q34593647

about

Virological features associated with the development of broadly neutralizing antibodies to HIV-1 HIV broadly neutralizing antibody targets HIV Epidemic in Asia: Implications for HIV Vaccine and Other Prevention Trials.New concepts in HIV-1 vaccine development Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies.Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost Phylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe Inhibitory Effect of Individual or Combinations of Broadly Neutralizing Antibodies and Antiviral Reagents against Cell-Free and Cell-to-Cell HIV-1 Transmission.Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.Phenotypic Correlates of HIV-1 Macrophage Tropism.Glycan-Dependent Neutralizing Antibodies Are Frequently Elicited in Individuals Chronically Infected with HIV-1 Clade B or C.Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model.Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies.Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins.Profiling the neutralizing antibody response in chronically HIV-1 CRF07_BC-infected intravenous drug users naïve to antiretroviral therapy.Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.How germinal centers evolve broadly neutralizing antibodies: the breadth of the follicular helper T cell response.An entry-competent intermediate state of the HIV-1 envelope glycoproteins.Determinants of HIV-1 broadly neutralizing antibody induction.The HIV-1 transmission bottleneck.Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.A single, continuous metric to define tiered serum neutralization potency against HIV.Neutralization tiers of HIV-1.Neutralization Sensitivity of a Novel HIV-1 CRF01_AE Panel of Infectious Molecular Clones.Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.Molecular basis of unusually high neutralization resistance in tier 3 HIV-1 strain 253-11.Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses Broadly neutralizing antibodies in HIV-1 treatment and prevention

P2860

Q27025177-174AA1E8-6395-4CB7-8B1B-3ED990B6FD8B Q27026662-C0C6D81A-551A-4D6C-B4C8-616B0067B981 Q27687375-82328256-3097-4AC9-83C4-39C5407F27C9 Q28067027-FF240159-97E9-4EB6-913C-845008E325F8 Q34594036-858B998A-2A1F-49B3-8E5E-FD619CB9A578 Q35677620-6D68B783-5B2B-4A7C-A43D-1DA5CE985707 Q35760486-2F3974BD-832E-4BD0-A9B3-A988E867C575 Q35850067-DD8FCFCE-148D-4592-99A0-2510D1845098 Q35861276-1D00F87C-F99A-4D3D-8358-D67F9415CAAE Q36081789-3B2EC8FC-244A-4B35-B49E-45D607D60579 Q36239578-08777993-E43B-481A-88E0-C8CC59588BA7 Q36281817-91366B5B-CF24-4CE2-9E21-8195000CC657 Q36294701-93D03157-70EB-495E-87C8-9D23405FDBC4 Q36337888-49BF67B5-B8AA-4765-822C-64720767E386 Q37246321-FA86D67F-292E-47F8-A84B-0789B441BA29 Q37366342-8529D4D6-FC30-4908-BD7F-A667DA6CF991 Q37741310-57A0EEE4-6B52-4817-B954-B79DC073C110 Q38659318-1469CB47-C30E-4F2C-AC6D-D70BF33A2750 Q39108779-D73992FB-522B-4C15-99F3-66606671EB92 Q40054979-8FEDE4F4-FEAB-44C9-85BB-A923DDFC9CD6 Q40104677-F0783167-F64B-4725-817A-0AB461C9BD92 Q40476608-84F84CBE-1555-479E-98FC-B02705C7D39D Q42314454-D0DE6C88-86DF-42DA-AF98-CF3A91241360 Q42638889-AB225E30-9162-46A3-A7D0-EC86BB8D654C Q44536209-59C23E1F-41A2-4D23-BB6B-349DA4E8EB95 Q47551447-02D51418-D5BA-40A8-8117-CE5BD77E47CE Q47562235-F76D6419-0D5B-44AD-81F9-37A63D95947B Q52660832-DF5DACD0-6EA7-4AC1-9202-8E485BF14FFD Q52673965-C9B91DCE-9825-44BD-8F4E-724EADFCD366 Q53693698-10419CCF-4458-45D2-8BDC-633CF2A107E0 Q53695792-FBEBA873-F0F3-4B80-9E2E-E1638A778D1B Q56974226-E44606DF-FBCC-4D8D-B8DC-059294E873FF Q57170667-AC8BFA13-D58C-41EB-8192-0F482045D039 Q57815702-75BD7C69-D91B-4CFE-A729-F065E1A96960

P2860

Impact of clade, geography, and age of the epidemic on HIV-1 neutralization by antibodies.

http://www.wikidata.org/entity/Q34593647

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Impact of clade, geography, an ...... neutralization by antibodies.

@ast

Impact of clade, geography, an ...... neutralization by antibodies.

@en

Impact of clade, geography, an ...... neutralization by antibodies.

@nl

type

label

Impact of clade, geography, an ...... neutralization by antibodies.

@ast

Impact of clade, geography, an ...... neutralization by antibodies.

@en

Impact of clade, geography, an ...... neutralization by antibodies.

@nl

prefLabel

Impact of clade, geography, an ...... neutralization by antibodies.

@ast

Impact of clade, geography, an ...... neutralization by antibodies.

@en

Impact of clade, geography, an ...... neutralization by antibodies.

@nl

P1433

Q34593647-02A27F7C-FCF3-472D-8B21-2191B5EF91C4

P1476

Q34593647-0B5629C5-D785-4EB3-B31F-BCF394D7002F

P2093

Q34593647-45DB3719-766C-4FD6-9A0F-A09DEF8B46B0

Q34593647-4F376B75-195C-4706-AC4B-2B70E5F843BF

Q34593647-6374A76B-23D0-48EF-9DCF-A073E982632E

Q34593647-6AF19152-F43F-4E4B-B5BE-3F1A3EF0CE1A

Q34593647-6F6DFD64-3679-4CB3-B79B-3C36305E2388

Q34593647-739BBFE3-C2C9-4C10-AA31-CE4BC9FF2980

Q34593647-85E6D820-8EF2-4995-A99B-6B4C82B2F7E5

Q34593647-D4FE1506-27A3-4D2E-9258-B52756EC4754

Q34593647-D59DCB27-29F1-4A1D-B694-5ABBB4666DBD

Q34593647-DBE0C003-999C-4849-B57D-8D4485B8EAAF

P2860

Q34593647-00DFC73E-3CE8-43B3-A7BE-F65256B8587B

Q34593647-04C9D25A-FB5C-4ADE-B4CB-8CF7DD09F9A5

Q34593647-065D4EE6-F3A7-4431-8FDF-C766CD03824C

Q34593647-06F9FF0E-5A06-4186-859D-9E3C6E24ED1F

Q34593647-07B4D9AB-E3E4-40D2-8582-99CCB3A8E864

Q34593647-08126F60-3EFA-4C64-83F1-C2C1D0CA711C

Q34593647-0A8CBC39-CD2C-4105-86E0-6C47643F1BB4

Q34593647-0ED1669D-AC6B-4202-9603-81565F038918

Q34593647-10B8A5BD-737B-4C7C-98D7-2A17F06AD347

Q34593647-11CE258F-CD90-4E74-85D6-2A7BF10B18DF

P304

Q34593647-C3208251-228D-48DC-A082-0207BB2824DC

P31

Q34593647-4C101ECD-AD55-4455-B012-462C33F0511A

P356

Q34593647-5A4D533C-4C5A-4FF0-9026-70DD70DAF5C2

P407

Q34593647-5673B4D6-3DA1-4013-8772-74C166C26A8F

P433

Q34593647-DD145CE8-3F2E-4FAC-AEC3-E8B1AD27021D

P478

Q34593647-9A626D6E-D64E-4DB0-ACE5-BC135D8BE0D0

P50

Q34593647-2457B9D6-BFBD-424F-8BCF-7C9EB4384145

Q34593647-32440DFB-6BFE-4224-A6DA-8D8C699B8300

Q34593647-53BFA8D2-32B7-42D6-B639-6B50165815CF

Q34593647-5F950529-03BF-421C-A412-EB0F156B31C9

Q34593647-73F7E4F1-4469-4157-8324-12C6C439A7B3

Q34593647-7E1B1E5F-6A20-43EE-A96C-7AF4D44F2AB7

Q34593647-89486D35-5ABF-4EC8-9D31-1A56FB55ACD7

Q34593647-A34466A8-A6CF-4B9F-819E-58D66E4A48BC

Q34593647-E9AC6E9F-6E72-4DA5-90CF-6B3DA0C0ADCE

Q34593647-EBBFCDD7-0F89-4638-ABD5-C2D07064E9D4

P577

Q34593647-E30CBD22-F835-4ED3-83E7-FA557A326897

P698

Q34593647-4B5C50B3-765F-4C54-AD70-F9CF6AD9C7BE

P921

Q34593647-96305977-97DB-42B9-BC49-47131C56EFE5

P932

Q34593647-9C9972B5-78CA-47BC-A926-56F0E3807EAE

P356

P1433

Journal of Virology

P1476

Impact of clade, geography, an ...... neutralization by antibodies.

@en

P2093

Alan S Lapedes

http://www.w3.org/2001/XMLSchema#string

Elena Giorgi

http://www.w3.org/2001/XMLSchema#string

Feng Gao

http://www.w3.org/2001/XMLSchema#string

Hongmei Gao

http://www.w3.org/2001/XMLSchema#string

Kelli M Greene

http://www.w3.org/2001/XMLSchema#string

Linda Harris

http://www.w3.org/2001/XMLSchema#string

Michael M Thomson

http://www.w3.org/2001/XMLSchema#string

Michael S Seaman

http://www.w3.org/2001/XMLSchema#string

Nicholas Hengartner

http://www.w3.org/2001/XMLSchema#string

Robert T Bailer

http://www.w3.org/2001/XMLSchema#string

P2860

HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960

Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies

Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals

Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses

Statistical significance for genomewide studies

A Blueprint for HIV Vaccine Discovery

Antibodies in HIV-1 vaccine development and therapy

Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

P304

12623-12643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01705-14

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Peter T. Hraber

Beatrice H. Hahn

Tanmoy Bhattacharya

Ronald Swanstrom

David C Montefiori

Carolyn Williamson

Francine E McCutchan

P577

2014-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25142591

http://www.w3.org/2001/XMLSchema#string

P921

P932

4248897

http://www.w3.org/2001/XMLSchema#string